CORC  > 湖南大学
Salvanic acid B inhibits myocardial fibrosis through regulating TGF-β1/Smad signaling pathway.
Gao Hongyan; Bo Zhe; Wang Qin; Luo Ling; Zhu Haiyi; Ren Yi
刊名Biomedicine & pharmacotherapy = Biomedecine & pharmacotherapie
2018
卷号Vol.110页码:685-691
关键词Myocardial fibrosis Salvanic acid B Signaling pathway
ISSN号1950-6007
URL标识查看原文
公开日期[db:dc_date_available]
内容类型期刊论文
URI标识http://www.corc.org.cn/handle/1471x/5460426
专题湖南大学
作者单位1.Chongqing Key Laboratory of Traditional Chinese Medicine to Prevent and Treat Autoimmune Diseases, Chongqing Hospital of Traditional Chinese Medicine, Chongqing 400021, PR China. Department of Cardiology, Chongqing Hospital of Traditional Chinese Medicine, Chongqing 400021, PR China. Department of Pharmacy, Chongqing Hospital of Traditional Chinese Medicine, Chongqing 400021, PR China. Department of Cardiology, Chongqing Hospital of Traditional Chinese Medicine, Chongqing 400021, PR China. Electronic address: yiren827722@16
2.com.
推荐引用方式
GB/T 7714
Gao Hongyan,Bo Zhe,Wang Qin,et al. Salvanic acid B inhibits myocardial fibrosis through regulating TGF-β1/Smad signaling pathway.[J]. Biomedicine & pharmacotherapy = Biomedecine & pharmacotherapie,2018,Vol.110:685-691.
APA Gao Hongyan,Bo Zhe,Wang Qin,Luo Ling,Zhu Haiyi,&Ren Yi.(2018).Salvanic acid B inhibits myocardial fibrosis through regulating TGF-β1/Smad signaling pathway..Biomedicine & pharmacotherapy = Biomedecine & pharmacotherapie,Vol.110,685-691.
MLA Gao Hongyan,et al."Salvanic acid B inhibits myocardial fibrosis through regulating TGF-β1/Smad signaling pathway.".Biomedicine & pharmacotherapy = Biomedecine & pharmacotherapie Vol.110(2018):685-691.
个性服务
查看访问统计
相关权益政策
暂无数据
收藏/分享
所有评论 (0)
暂无评论
 

除非特别说明,本系统中所有内容都受版权保护,并保留所有权利。


©版权所有 ©2017 CSpace - Powered by CSpace